News Detail
Maryland, 3 Aug 2023: The US Food and Drug Administration (FDA) has reprimanded two drugmakers — Avlon Industries based in Melrose Park, Illinois, and Medgel based in Pithampur, Madhya Pradesh, India — over identity testing and other good manufacturing practice (......
View Details
Source : Regulatory Focus
US Food and Drug Administration (FDA)
Avlon Industries Melrose Park Illinois
Medgel based in Pithampur
good manufacturing practice (GMP) lapses
diethylene glycol (DEG) or ethylene glycol (EG) contamination
Related News
- Sriganganagar: Massive crackdown on drug traders, 14032 pills and capsules seized (23-09-2023)
- Action against three traders in Jamnagar city for selling duplicate beauty products (23-09-2023)
- Hoshiarpur: Action against person running medical store without license, 35 types of banned medicines seized (23-09-2023)
- Pharma exports grow 4.53% in August, imports grow 20% (23-09-2023)
- Fujifilm India installs 125 AMULET Innovality digital mammography machines across India (23-09-2023)
- Abbott India warns of laxatives shortage in tussle with Goa regulator (23-09-2023)
- J&K: 'Fake doctor' enters LD hospital's labour room, Govt appoints inquiry officer (22-09-2023)
- In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)